Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30468202 | 0.89 | FFAR1 (0.47) | FFAR1ALDH1A1KDM4EMEN1NPC1 | |
| SCHEMBL2466535 | 0.89 | FFAR1 (0.47) | FFAR1ALDH1A1KDM4EMEN1NPC1 | |
| SCHEMBL29038518 | 0.80 | NQO2 (0.39) | FFAR1ALDH1A1NPC1CYP1A2MAPT | |
| SCHEMBL12408477 | 0.80 | FFAR1 (0.59) | FFAR1ALDH1A1KDM4EMEN1NPC1 | |
| SCHEMBL2173149 | 0.79 | FFAR1 (0.41) | FFAR1ALDH1A1KDM4EMEN1NPC1 | |
| SCHEMBL28016124 | 0.79 | FFAR1 (0.41) | FFAR1ALDH1A1KDM4EMEN1NPC1 | |
| SCHEMBL1920588 | 0.78 | FFAR1 (0.57) | FFAR1ALDH1A1KDM4EMEN1NPC1 | |
| SCHEMBL10623230 | 0.78 | APP (0.57) | FFAR1ALDH1A1KDM4EMEN1NPC1 | |
| SCHEMBL29843195 | 0.78 | FFAR1 (0.57) | FFAR1ALDH1A1KDM4EMEN1NPC1 | |
| SCHEMBL28401249 | 0.77 | FFAR1 (0.40) | FFAR1ALDH1A1MAPK1CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7705174-B2 | Condensed polycyclic π-conjugated organic material, intermediate product therefor, and method of manufacturing condensed polycyclic π-conjugated organic material | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-04-27 | — | — | US | disclosed |
| US-7705174-B2 | Condensed polycyclic π-conjugated organic material, intermediate product therefor, and method of manufacturing condensed polycyclic π-conjugated organic material | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-04-27 | — | — | US | disclosed |
| US-20060100433-A1 | n-conjugated organic material of polycyclic fused ring type,intermediate therefor, and process for producing n-conjugated organic material of polycyclic fused ring type | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2006-05-11 | — | — | US | disclosed |
| EP-1548019-A1 | -CONJUGATED ORGANIC MATERIAL OF POLYCYCLIC FUSED RING TYPE, INTERMEDIATE THEREFOR, AND PROCESS FOR PRODUCING-CONJUGATED ORGANIC MATERIAL OF POLYCYCLIC FUSED RING TYPE | Japan Science and Technology Agency (JP) | 2005-06-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060100433-A1 | n-conjugated organic material of polycyclic fused ring type,intermediate therefor, and process for producing n-conjugated organic material of polycyclic fused ring type | SLC39A11, NQO1, SLC43A1 | FFAR1 2173/4885ALDH1A1 779/4885KDM4E 3880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.